Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Shengxue
- Development stage
- Preclinical
- Lead developer
- Xiyuan Hospital
- Administration
- Oral
01
Overview
Bushen Shengxue is a Traditional Chinese Medicine (TCM) formula developed by Xiyuan Hospital of the China Academy of Traditional Chinese Sciences, specifically for the treatment of aplastic anemia. The formula is based on the TCM principle of "tonifying the kidney to generate blood" (Bushen Shengxue), which aims to restore hematopoietic function and improve clinical outcomes in patients with bone marrow failure. It is frequently studied and administered in combination with "Nourishing Qi" (Yi Qi) methods. Clinical research, including randomized controlled trials registered in the Chinese Clinical Trial Registry (ChiCTR), has focused on its potential to increase curative rates and decrease recurrence rates in aplastic anemia by modulating the immune system and supporting the bone marrow microenvironment.
- Other names
- Bushen Shengxue formulaBushen Shengxue decoctionBushen Shengxue granule
02
Targets
Vascular endothelial growth factor/Vascular endothelial growth factor receptor 2 signaling axisKIT (c-KIT proto-oncogene receptor tyrosine kinase)
Beyond the preview
Go deeper on Bushen Shengxue.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bushen Shengxue.